Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology
Open Access
- 20 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 13 (6), 669-679
- https://doi.org/10.1093/neuonc/nor025
Abstract
This study was designed to confirm the previously observed favorable survival rates and prognostic factors in young children with nonmetastatic medulloblastoma (MB) treated with postoperative chemotherapy alone. Patients who received a diagnosis during the period January 2001 through December 2005 and who were aged P < .001 for EFS; P = .008 for OS). Five-year EFS and OS rates for 3 children with anaplastic MB were 33% ± 27%. Desmoplastic/nodular histology was an independent prognostic factor for EFS. Twenty-nine of 30 patients without postoperative residual tumor remained in continuous complete remission. Our results confirm that histology of MB variants is a strong prognostic factor in this age group. Sustained tumor control can be achieved by this chemotherapy regimen in young children with desmoplastic/nodular MB variants. For children with non-desmoplastic/nonnodular MB variants, for which predominantly local relapses lead to less favorable survival rates, local radiotherapy has been introduced after chemotherapy since 2006.Keywords
This publication has 34 references indexed in Scilit:
- Medulloblastoma in young childrenPediatric Blood & Cancer, 2010
- Medulloblastoma Variants: Age-Dependent Occurrence and Relation to Gorlin Syndrome—A New Clinical PerspectiveClinical Cancer Research, 2009
- Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapyNeuro-Oncology, 2009
- Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological FeaturesPLOS ONE, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic AlterationsJournal of Clinical Oncology, 2006
- Prediction of central nervous system embryonal tumour outcome based on gene expressionNature, 2002
- Medulloblastoma with extensive nodularity: a variant with favorable prognosisJournal of Neurosurgery, 1999
- The treatment of malignant brain tumors in infants and very young children: An update of the Pediatric Oncology Group experienceNeuro-Oncology, 1999
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958